Menu
GWAS Study

Genome-wide association studies identify novel loci in rapidly progressive Alzheimer's disease.

Wang P, Lynn A, Miskimen K et al.

38184787 PubMed ID
GWAS Study Type
384 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WP
Wang P
LA
Lynn A
MK
Miskimen K
SY
Song YE
WT
Wisniewski T
CM
Cohen M
AB
Appleby BS
SJ
Safar JG
HJ
Haines JL
Chapter II

Abstract

Summary of the research findings

Introduction: Recent data suggest that distinct prion-like amyloid beta and tau strains are associated with rapidly progressive Alzheimer's disease (rpAD). The role of genetic factors in rpAD is largely unknown.

96 European, African American, Asian, American Indian/Alaska Native or unknown ancestry cases, 288 European, African American, Asian, American Indian/Alaska Native or unknown ancestry controls

Chapter III

Study Statistics

Key metrics and study information

384
Total Participants
GWAS
Study Type
No
Replicated
European, African American or Afro-Caribbean, NR, Asian unspecified, Native American
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.